Constronics Infra Ltd.
Snapshot View

6.90 ▼0%

06 October 2022, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.constronicsinfra.com
Market Cap 4.97 Cr.
Enterprise Value(EV) 5.93 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.22 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 31.48 Trailing Twelve Months Ending 2022-06
Industry PE 49.90 Trailing Twelve Months Ending 2022-06
Book Value / Share 0.15 Trailing Twelve Months Ending 2022-06
Price to Book Value 45.16 Calculated using Price: 6.90
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.72 Cr. 7,209,041 Shares
FaceValue 10
Company Profile
Invicta Meditek Limited (Invicta) incorporated in 1992 is a Public Limited company engaged in the manufacture of quality Orthopaedic Implants and Instruments.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-9.80%
1 Month
+0.73%
3 Month
+1.92%
6 Month
-28.35%
1 Year
-17.86%
2 Year
+60.47%
5 Year
+76.47%
10 Year
-63.00%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -6.86 -6.88 -10.77 -12.17 -14.42 -42.43 -171.88 192.41 -138.75
Return on Capital Employed (%) -6.80 -6.78 -10.74 -12.13 -14.10 -20.15 -2.97 11.11 -9.14
Return on Assets (%) -4.86 -4.10 -5.95 -6.02 -6.25 -11.92 -2.40 8.89 -8.66

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 1 1 1 1 1 0 0 0 0
Non Curr. Liab. 1 0 0 1
Curr. Liab. 1 1 1 1 1 0 1 1 1 0
Minority Int.
Equity & Liab. 1 1 1 1 1 1 1 1 1 1
Non Curr. Assets 0 0 0 0 0 1 1 1 1 1
Curr. Assets 1 1 1 1 1 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 1 1 1 1 1 1 1 1 1 1

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 1 2 2 2
Other Income 0 0 0
Total Income 0 1 2 2 2
Total Expenditure 0 0 0 0 0 0 -1 -2 -2 -2
PBIDT 0 0 0 0 0 0 0 0 0 0
Interest 0
Depreciation 0
Taxation 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0
Cash Fr. Inv.
Cash Fr. Finan. 0 0 0
Net Change 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 16.58 16.58 16.58 16.58 18.47 18.47 18.47 18.47 18.47
Public 83.42 83.42 83.42 83.42 81.53 81.53 81.53 81.53 81.53
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 01 Oct 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the 30th Annual General Meeting of the Company was duly held on Thursday the 29th day of September 2022 at 10.00 AM (1ST) and the business mentioned in the Notice convening the AGM were transacted. We herewith enclosed the following documents for your reference and records:1. The Voting Results of the business transacted at the 30th Annual General Meeting of the Company as required under Regulation 44 of the SEBI Listing Regulations.2. Report of the Scrutinizer dated 1st October 2022 pursuant to Section 108 of the Companies Act 2013 and Rule 20 of the Companies (Management and Administration) Rules 2014.
Thu, 29 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 read with para A of Part A of Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that the 30th Annual General Meeting of the Company was duly held on Thursday the 29th day of September 2022 at 10.00 AM at the Registered Office of the Company and the proceedings of the said meeting is herewith submitted
Sat, 10 Sep 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to regulation 47(3) of SEBI (LODR) Regulation 2015 we hereby enclosed the Notice of the 30th Annual General Meeting to be held on 29th September 2022 published in Financial Express and Malai Murasu on 8th September 2022.

Technical Scans View Details >>

Thu, 06 Oct 2022
Opening at High Opening at High
Opening at High for 3 days Opening at High for 3 days
Closing Below Previous Low Closing Below Previous Low
High Decrease 6 Months High Decrease 6 Months
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,656.62 953.00 -0.1%
Divi's Laboratories Ltd. 99,250.74 3,738.70 +0.0%
Cipla Ltd. 91,332.41 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. 72,821.94 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. 63,207.02 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. 53,000.56 1,566.00 -2.3%
Zydus Lifesciences Ltd. 42,689.71 421.75 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.79 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.96 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 36.70 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.35 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.55 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.17 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.66 421.75 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.56 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 4.25 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.60 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.64 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.29 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.54 421.75 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 421.75 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 421.75 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 421.75 -0.3%

FAQ's On Constronics Infra Ltd.

What is Constronics Infra share price?

Can I buy Constronics Infra shares now?

What is the Market Cap of Constronics Infra?

What are the key metrics to analyse Constronics Infra?

What is the 52 Week High and Low of Constronics Infra?